FluidAI Medical

AIDigital Health & HealthTechKitchener, ON

Kitchener company selling Origin, an FDA-cleared surgical-drain sensor, and Stream Care, machine-learning software that combines sensor and EHR data to flag postoperative complication risk after GI surgery.

The Toronto skyline and the CN Tower at sunset, seen across Lake Ontario.

Canadian innovation builds a brighter tomorrow.

About

Company site: fluidai.md

Kitchener company selling Origin, an FDA-cleared surgical-drain sensor, and Stream Care, machine-learning software that combines sensor and EHR data to flag postoperative complication risk after GI surgery.

  • Federal corporation NERV TECHNOLOGY INC. (BN 801509431), status Active, registered office in Kitchener, incorporated 2014-05-29 — now operating as FluidAI Medical. ised-isde.canada.ca

  • Origin received US FDA 510(k) clearance as a Class 2 device on October 2, 2025, opening US sales for the surgical-drain monitor. fluidai.md

  • FedDev Ontario invested $2M CAD (July 2025) to help the company scale manufacturing and commercialize Origin and Stream Care. prnewswire.com

  • Raised a $15M Series A in October 2023 led by SOSV and Graphene Ventures, with Boutique Venture Partners, Threshold Impact, Cur8 Capital, Leva Capital and others. fluidai.md

  • Works with 50+ global health partners in 4+ countries including Cleveland Clinic and St. Michael's Hospital, per its own site. fluidai.md

Products & Services

Company site: fluidai.md

Products FluidAI Medical publishes on its own site. Each card links to the page it was taken from.

Origin

Surgical-drain biochemical sensor

A device that attaches to surgical drains and continuously monitors the biochemical composition of drainage fluid to help detect anastomotic leakage early; FDA 510(k)-cleared and Health Canada-cleared.

Learn more

Stream Care

AI postoperative risk software

Combines Origin's sensor data with electronic health record data using machine-learning algorithms to assess postoperative complication risk after gastrointestinal surgery.

Learn more

Stream Inara

AI patient engagement platform

AI-powered patient education and engagement platform that monitors patients after hospital discharge, collects outcomes data, and provides personalized education and support, enhanced by the acquired Emmetros SparxConnect technology.

Learn more Source

Funding & Investors

Announced rounds only, newest first. Undisclosed amounts are shown as undisclosed.

  1. Series A

    Oct 10, 2023

    Investors: SOSV, Graphene Ventures, Boutique Venture Partners, Threshold Impact, Cur8 Capital, Leva Capital, Kyto Technology & Life Science, Juno Pharmaceuticals

Total disclosed: US$15.0MLatest: Series A · Oct 10, 2023

Government & Grants

Government support actually received. Unpublished amounts are left out.

  1. FedDev Ontario — manufacturing and commercialization of AI-driven postoperative care technology

  2. CanExport SME, National Research Council Canada

  3. Youth - Canada Summer Jobs, Employment and Social Development Canada

  4. Industrial Research Assistance Program – AI Assist, National Research Council Canada

  5. CanExport SME, National Research Council Canada

  6. Industrial Research Assistance Program – Youth Employment Program, National Research Council Canada

  7. Youth - Canada Summer Jobs, Employment and Social Development Canada

  8. Business Scale-up and Productivity (BSUP), Federal Economic Development Agency for Southern Ontario

  9. Youth - Canada Summer Jobs, Employment and Social Development Canada

  10. Industrial Research Assistance Program – Contributions to Firms, National Research Council Canada — contribution

  11. Youth - Canada Summer Jobs, Employment and Social Development Canada

Recent News

  1. Nov 26, 2025Acquisition

    FluidAI Medical announces an acquisition deal with Emmetros Limited

    FluidAI acquired Emmetros, developer of the SparxConnect patient engagement platform, to strengthen its Stream Inara post-discharge product within its RISE surgical-journey program.

  2. Oct 2, 2025Product

    FluidAI Medical's Origin device has received FDA 510(k) clearance

    Origin, FluidAI's inline surgical-drain sensor, received FDA 510(k) clearance as a Class 2 device, allowing US sales of the real-time bedside postoperative monitor.

  3. Jul 9, 2025Government

    FluidAI secures a $2-million Government of Canada investment to accelerate global commercialization

    FedDev Ontario invested $2M CAD to help FluidAI Medical scale manufacturing and speed commercialization of Origin and Stream Care.

  4. Oct 10, 2023Funding

    FluidAI Medical raises $15M Series A for its AI-driven postoperative monitor

    FluidAI Medical closed a $15M Series A led by SOSV and Graphene Ventures to expand into global markets and grow R&D on its postoperative complication technology.

People

Sourced from the company's own pages or announcements.

Youssef Helwa

Co-Founder and Chief Executive Officer

Technology Focus

Company site: fluidai.md

Terms the company uses about its own work.

Postoperative monitoringBiochemical sensingMachine learning risk prediction

Similar Companies

Other companies in AI.

Join Canada’s innovation community.

Discover companies, track funding, explore career opportunities and stay informed about Canada’s growing tech ecosystem.

624
Verified Companies
45
Funding Opportunities
19
Sectors
A stronger Canada together